-
EP3374399
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3374399
| EP3374399 - COMPOSITION AND METHODS FOR ANTI-TNFR2 ANTIBODIES [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 07.06.2019 Database last updated on 29.10.2024 | |
| Former | Request for examination was made Status updated on 17.08.2018 | ||
| Former | The international publication has been made Status updated on 19.05.2017 | Most recent event Tooltip | 07.06.2019 | Withdrawal of application | published on 10.07.2019 [2019/28] | Applicant(s) | For all designated states Opi Vi- IP Holdco LLC 601 Lexington Avenue 54th Floor New York, NY 10022 / US | [2018/38] | Inventor(s) | 01 /
THOMPSON, Peter, Armstrong 14075 NE 30th Place Bellevue, WA 98007 / US | [2018/38] | Representative(s) | Avidity IP Broers Building Hauser Forum 21 JJ Thomson Avenue Cambridge CB3 0FA / GB | [2018/38] | Application number, filing date | 16865005.9 | 10.11.2016 | [2018/38] | WO2016US61343 | Priority number, date | US201562254127P | 11.11.2015 Original published format: US 201562254127 P | [2018/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017083525 | Date: | 18.05.2017 | Language: | EN | [2017/20] | Type: | A1 Application with search report | No.: | EP3374399 | Date: | 19.09.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.05.2017 takes the place of the publication of the European patent application. | [2018/38] | Search report(s) | International search report - published on: | US | 18.05.2017 | Classification | IPC: | C07K16/28, C07K16/30, A61K39/395, A61P35/00 | [2018/38] | CPC: |
C07K16/2878 (EP,US);
A61P35/00 (EP);
C07K2317/21 (US);
C07K2317/24 (EP,US);
C07K2317/33 (EP,US);
C07K2317/71 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/38] | Title | German: | ZUSAMMENSETZUNG UND VERFAHREN FÜR ANTI-TNFR2-ANTIKÖRPER | [2018/38] | English: | COMPOSITION AND METHODS FOR ANTI-TNFR2 ANTIBODIES | [2018/38] | French: | COMPOSITION ET MÉTHODES POUR ANTICORPS ANTI-TNFR2 | [2018/38] | Entry into regional phase | 30.05.2018 | National basic fee paid | 30.05.2018 | Search fee paid | 30.05.2018 | Designation fee(s) paid | 30.05.2018 | Examination fee paid | Examination procedure | 30.05.2018 | Examination requested [2018/38] | 30.05.2018 | Date on which the examining division has become responsible | 14.12.2018 | Amendment by applicant (claims and/or description) | 29.05.2019 | Application withdrawn by applicant [2019/28] | Fees paid | Renewal fee | 27.11.2018 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY]US2008176796 (BRADLEY JOHN [GB], et al) [X] 2 * ; paragraphs [0016], [0031]-[00322], [0096] * [Y] 1; | [Y]US2006039857 (ADCOCK DEBORAH K [US]) [Y] 1 * ; abstract; paragraphs [0010]-[0011], [0024] *; | [A]US2013251672 (LENTZ M RIGDON [DE]) [A] 1-2 * ; entire document *; | [EX]WO2016187068 (MASSACHUSETTS GEN HOSPITAL [US]) [EX] 1-2 * ; entire document * | [A] - GRAZIEWICZ, MA et al., "An Endogenous TNF-[alpha] Antagonist Induced by Splice-switching Oligonucleotides Reduces Inflammation in Hepatitis and Arthritis Mouse Models.", Molecular Therapy., (20080700), vol. 16, no. 7, pages 1316 - 1322, XP002582508 [A] 1-2 * ; DOI: 10.1038/mt.2008.85 * DOI: http://dx.doi.org/10.1038/MT.2008.85 |